4-Hydroxyphenylboronic acid

We are 4-Hydroxyphenylboronic acid CAS:71597-85-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 4-Hydroxyphenylboronic acid
Other Name:
4-Hydroxyphenylboronic acid
(4-hydroxyphenyl)boronic acid
CAS No: 71597-85-8
MF: C6H7BO3
MW: 137.92900
Density: 1.32 g/cm3
Boiling point: 351.4ºC at 760 mmHg
Melting point: >230 °C(lit.)
Flash point: 166.3ºC
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: Off-white to light brown powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Applicationd in OLED intermediates, pharmaceutical intermediate.
Mainly used in Suzuki coupling reactions.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

4-Hydroxyphenylboronic acid


Related News: The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.1-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)piperazine The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.206190-14-9 Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.Acido metanilico CAS:121-47-1 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
Dermcidin-1L(human) View Details
(1S,4R)-Methyl 4-((tert-butoxycarbonyl)amino)cyclopent-2-enecarboxylate View Details
1-(bromomethyl)-2-(trifluoromethoxy)benzene View Details
2,7-Dibromo-9,9-Spiro-Bifluorene manufacturer 4-Iodobutyl acetate manufacturer 3,6-Dichloropyridazine manufacturer 3,5-Difluoroaniline manufacturer Methyl cyclobutanecarboxylate manufacturer